The difference between dabigatran etexilate capsules (Pradaxa) and rivaroxaban (Rivaroxaban)

Dabigatran etexilate capsules (Pradaxa) and rivaroxaban (Rivaroxaban) both belong to a new generation of oral anticoagulants. They are direct thrombin inhibitors and thrombinXa inhibitors, respectively used to prevent and treat thrombosis-related diseases. Although they have similarities in their mechanisms of action and applications, there are significant differences in some aspects.

First of all, in terms of mechanism of action:

1.Dabigatran etexilate capsule (Pradaxa): Its main ingredient is dabigatran etexilate, which is a direct thrombin inhibitor. Dabigatran etexilate effectively prevents thrombosis by directly inhibiting the activity of thrombin and preventing the formation of fibrin.

2.Rivaroxaban (Rivaroxaban): This is a thrombinXa inhibitor. It inhibits the activity of thrombinXa and prevents the coagulation cascade reaction, thereby slowing down the blood clotting process.

There are also some differences in application:

1.Indications:

Dabigatran etexilate capsule: It is mainly used for stroke prevention, treatment of deep vein thrombosis and pulmonary embolism in patients with non-valvular atrial fibrillation, and anticoagulation after surgery.

Rivaroxaban: Indicated for stroke prevention, treatment of deep vein thrombosis and pulmonary embolism in patients with non-valvular atrial fibrillation, and treatment of stable coronary artery disease associated with coronary heart disease.

2.How to take:

Dabigatran etexilate capsules: It is a fixed-dose capsule that needs to be taken regularly with food.

Rivaroxaban: is a tablet that is usually taken once daily with or without food.

3.Monitoring and reversibility:

Dabigatran etexilate capsules: Routine regular monitoring is not requiredINR (International Normalized Ratio), but its anticoagulant effect is reversible and its effect can be quickly reversed by reversal agents.

Rivaroxaban: Regular monitoring is usually not required, but testing may be needed in some patients. Its anticoagulant effect is relatively predictable and does not require reversal agents.

4.Kidney function:

Dabigatran etexilate capsules: Affected to a certain extent by renal function, so dose adjustment may be required in patients with impaired renal function.

Rivaroxaban: Also related to renal function and may require dose adjustment in patients with impaired renal function.

5.Drug interactions:

Dabigatran etexilate capsules: Potential interactions with some medications may require dose adjustment or monitoring.

Rivaroxaban: It may also interact with some drugs, and patients need to inform their doctors about other drugs they are taking.

Taken together, although dabigatran etexilate capsules and rivaroxaban have similar goals in anticoagulant therapy, they have some significant differences in their mechanisms of action, indications, administration methods, and monitoring. Before using these drugs, patients should fully understand their characteristics and indications according to the doctor's advice, and receive regular monitoring to ensure the effectiveness and safety of the drugs.

Dabigatran etexilate capsules have been launched in China and have been included in medical insurance. Patients can purchase them domestically. Please consult the local hospital pharmacy for specific prices. Foreign countries mainly use the original drug of dabigatran etexilate capsules, and the cheaper version is the Turkish version of the German original drug, specificationsThe price of 110mg*60 capsules is about three to four hundred, and the ingredients and efficacy are consistent with the original drugs on the market in China.